Spotlight -

B + L Dry Eye Series|

Transforming Glaucoma Management|

Zeiss Clinical Cases

Viewing

|Videos|August 19, 2020

What is the future of ophthalmology?

Author(s)Alex Delaney-Gesing

Ophthalmologists share their outlook for the current state and future of the ophthalmic profession, how coronavirus pandemic has altered the profession as well as how —now, more than ever — patient care remains a number one priority for ophthalmologists.

Vitreoretinal surgeons Daniel Kiernan, MD, FACS; Justis Ehlers, MD; and Dilraj Grewal, MD, speak with Ophthalmology Times'® David Hutton on their outlook for the current state and future of the ophthalmic profession, how coronavirus pandemic has altered the profession as well as how —now, more than ever — patient care remains a number one priority for ophthalmologists.

Newsletter

Don’t miss out—get Modern Retina updates delivered straight to your inbox.

Related Content

(Image credit: Modern Retina) Clinical Trials at the Summit 2026: First-time data, AI, and the next generation of retinal treatments

Clinical Trials at the Summit 2026: First-time data, AI, and the next generation of retinal treatments

ByArshad M. Khanani, MD, MA, FASRS,Sheryl Stevenson

June 9th 2026

Intracortical visual prosthesis: A new chapter in advancing visual restoration

ByLynda Charters

May 21st 2026

(Image credit: AdobeStock/izzuan) Retina World Congress 2026: Rethinking macular hole surgery without gas tamponade

Retina World Congress 2026: Rethinking macular hole surgery without gas tamponade

BySiegfried G. Priglinger, MD, FEBO,Sheryl Stevenson

May 17th 2026

(Image credit: Modern Retina) The Retina TL;DR with Dr. Weng: Exploring neuroprotection with ONL1204 and David Zacks, MD, PhD

The Retina TL;DR with Dr. Weng: Targeting the Fas signaling pathway with David Zacks, MD, PhD

ByChristina Y. Weng, MD, MBA, FASRS,David Zacks, MD, PhD

January 13th 2026

PRIMAvera study: Central vision improvement with subretinal implant

ByLynda Charters

January 8th 2026

Latest CME

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Neel Pasricha, MD; Asim V. Farooq, MD; Susana Campos, MD, MPH

Treatment Optimization in the Evolving Anti-VEGF Era

Treatment Optimization in the Evolving Anti-VEGF Era

Carl Danzig, MD, FASRS; Sruthi Arepalli, MD; Priya Vakharia, MD, FASRS

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Deep Parikh, MD

(CME Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

(CME Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

Mary Qiu, MD; Paul Singh, MD; Danica J. Marrelli, OD, FAAO

(COPE Track) Emerging Therapeutic Advancements in Dry Eye Disease Management

(COPE Track) Emerging Therapeutic Advancements in Dry Eye Disease Management

Rahul Tonk, MD; Jade Coats, OD, FAAO; Aaleya Koreishi, MD; Zeba Syed, MD

Trending on Eye Care Network - Ophthalmology Times

Comments from the FDA Advisory Committee meeting on SYD-101

OCT-980 receives FDA orphan drug designation for retinitis pigmentosa

FAQ: Diabetic eye disease awareness month 2026

First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP

Mediterranean diet linked to slower AMD progression across stages